Anthracycline based chemotherapies could have greater negative effects on cognition than nonanthracycline treatments for breast cancer survivors, a new study reports. Read More
Advertisements
Patients who experience chemobrain after treatment for cancer show brain network disruptions, researchers report. Read More
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas. Read More
Manipulating gut bacteria in mice before chemotherapy reduces the mental fog of "chemo brain." Read More
Researchers use focused ultrasound to safely and non-invasively open the blood-brain barrier in Alzheimer's patients. Read More
Researchers gain inspiration for creating tiny artificial brains, that can be used for cancer research, from an ancient Japanese art of flower arranging. Read More
Researchers report children who received chemotherapy alone for acute lymphoblastic leukemia remain at risk for attention and learning problems after the treatment ends. Read More
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain. Read More
An inhibitor of the 20-HETE chemical has been used to successfully control the spread and growth of human glioblastoma and breast cancer in lab models of the diseases, researchers report. Read More
Researchers have successfully used focused ultrasound to non-invasively penetrate the blood-brain barrier and deliver chemotherapy to a patient with brain cancer. Read More
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports. Read More
A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers. Read More
